FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
The FDA does not review compounded drugs for safety, effectiveness, or quality; compounded medications are not FDA-approved
Obesity Information Center
Using Nutrition as Medicine for Mental Health
Expert discusses identifying and managing nutrient deficiencies or eating habits that can contribute to mental health conditions including depression and anxiety
Specific Postoperative Complications Increased for Patients With Obesity
Odds of infection, venous thromboembolism, renal complications increased for patients with overweight, obesity.
Certain Wegovy Strengths Expected to Be in Short Supply
Wegovy is a glucagon-like peptide-1 receptor agonist.
Substantial Weight Loss Reductions Observed With Tirzepatide in T2D Patients
Tirzepatide is a once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.
Higher Dietary Choline, Betaine Intake May Benefit Individuals With Obesity
Researchers analyzed the relationship between dietary choline and betaine intake and serum lipids, blood pressure, and glycemic markers among individuals with obesity.
Coming Soon: Personalized Medicine for Weight Loss
Dr Zhaoping Li discusses 2 ongoing studies investigating the use of precision nutrition for personalized weight loss plans.
Obesity Drivers Differ by Sex
The findings contribute to the understanding of neurological factors driving the sex-specific pathophysiology of obesity.
COVID-19 Pandemic Increased Americans’ Concerns About Obesity
The researchers found that nearly 3 in 10 Americans became more worried about having obesity, with greater concern seen among Black and Hispanic Americans.
PA Provides Roadmap for Obesity Treatment Programs
Karli Burridge’s interest in obesity medicine began shortly after earning her PA degree and led her to cofound PAs in Obesity Medicine and Gaining Health, which help clinicians start obesity treatment programs.
Clinicians Weigh In on AAP Childhood Obesity Guideline
Survey respondents are cautious about the long-term effects of using antiobesity medications and bariatric surgery as recommended in the AAP childhood obesity guideline.
Greater HbA1c, Weight Loss Reductions Seen With Oral Semaglutide at Higher Doses
Novo Nordisk plans to file for regulatory approval of the 25mg and 50mg dosage strengths in 2023.
Semaglutide and Tirzepatide: Top 5 Things Clinicians Should Know
Obesity experts discuss how semaglutide and tirzepatide are changing the treatment landscape and challenges affecting access including drug shortages, inappropriate prescribing, insurance coverage, and cost.
Results of Liraglutide Therapy for Obesity in Real-World Setting
A study was conducted to determine real-world outcomes for patients taking liraglutide, lorcaserin, or orlistat therapy for obesity.
NP Profile: Gina A. Friel, DNP, RN, CRNP-PC, Creates Screening Process for Childhood Obesity
Gina A. Friel, DNP, RN, CRNP-PC discusses her interest in patients with overweight and obesity, food insecurity, and her efforts to improve health and wellbeing, diet quality, and social equity.
More than 60% of Adults With Type 1 Diabetes Have Overweight, Obesity
Those with type 1 diabetes are least likely to increase physical activity, reduce caloric intake to manage overweight or obesity.
We Have Better Obesity Medications, but Access Is Lagging
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
Maker of Weight-Loss Drug Wegovy Ramps Up Production to Meet Demand
The company expects ‘pent-up demand’ for the Wegovy (semaglutide) to subside within the next few months
More Support and Critique of AAP Guideline for Childhood Obesity
Two more medical societies have come out in support of the AAP’s updated clinical guidelines for obesity treatment in children and adolescents and one opposes it.
Supervised Aerobic Exercise Cuts Long-Term Diabetes Risk With Obesity
One-year moderate, vigorous exercise programs tied to reduction in 10-year risk for diabetes among adults with obesity.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...